Provisional figures on participation in the National Immunisation Programme According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
National Immunisation Programme: new decline in number of reported cases of disease in 2021 In 2021, fewer people contracted diseases for which vaccines are offered under the National Immunisation Programme (NIP) than before the coronavirus pandemic. This is very likely largely due to the impact of the coronavirus measures, such as social distancing and hand washing.
Patient with cutaneous diphtheria in reception centre This week, a refugee from Syria was found to be infected with the diphtheria bacterium. The patient has been treated with antibiotics. The patient’s contacts have been tested and vaccinated.
Side effect reports National Immunisation Programme 2021 Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
Target group-oriented information more effective in the prevention of skin cancer Avoid sunburn. This is the main advice for the prevention of skin cancer. Targeted information is needed to ensure that people adapt their behaviour accordingly. In places where people are exposed to the sun, for example, or for certain groups of peo
Participation in National Immunisation Programme shows slight decrease Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.